Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Randomized Study of Efficacy and Safety of 1c Class Antiarrhythmic Agent (Propafenone) in Septic Shock

NCT03029169 is registered in ClinicalTrials.gov with Charles University, Czech Republic as lead sponsor.

NCT NCT03029169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03029169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Randomized Study of Efficacy and Safety of 1c Class Antiarrhythmic Agent (Propafenone) in Septic Shock
Lead sponsor
Charles University, Czech Republic
Phase
Phase 4
Overall status
Completed
Start date
October 23, 2017
Completion date
August 1, 2022
Enrollment
210 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock, supraventricular arrhythmia